2011
DOI: 10.1177/000313481107700145
|View full text |Cite
|
Sign up to set email alerts
|

Positron Emission Tomography and Carcinosarcoma of the Esophagus

Abstract: Brief Reports should be submitted online to www.editorialmanager.com/ amsurg. (See details online under ''Instructions for Authors''.) They should be no more than 3 double-spaced pages excluding an Abstract and sub-headings with a maximum of four (4) references. If figures are included, they should be limited to two (2). The cost of printing color figures is the responsibility of the author.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…18 F-FDG PET/CT findings of esophageal carcinosarcoma have rarely been reported before. Esophageal carcinosarcoma also shows a hypermetabolic mass with SUV max ranging from 3.2 to 13.9 2,3,15 . For this case, it should be differentiated from squamous cell carcinoma, neuroendocrine tumor, melanoma, malignant fibrous histiocytoma, sarcoma, and other rare malignant tumor 4 .…”
mentioning
confidence: 95%
“…18 F-FDG PET/CT findings of esophageal carcinosarcoma have rarely been reported before. Esophageal carcinosarcoma also shows a hypermetabolic mass with SUV max ranging from 3.2 to 13.9 2,3,15 . For this case, it should be differentiated from squamous cell carcinoma, neuroendocrine tumor, melanoma, malignant fibrous histiocytoma, sarcoma, and other rare malignant tumor 4 .…”
mentioning
confidence: 95%